OptumRx Inc.
http://www.optumrx.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From OptumRx Inc.
Madrigal’s Rezdiffra Brings In $14.6m During Its First Quarter
The first approved NASH drug topped revenue expectations during its initial quarter on the market, but Madrigal’s share price declined by 12%.
PBM Execs Stay On Message Amid Growing US Congressional Frustration At Hearing
The House Oversight Committee held its third hearing on pharmacy benefit manager reforms in 14 months, but could not elicit an admission from executives that they are responsible for increasing drug prices.
Mark Cuban: Pharma’s Secret Weapon In The Fight Against PBMs
The well-known businessman and TV personality told the White House that the US needs to ‘stop doing business with the big three PBMs,’ helping to fight the drug industry’s battle against the middlemen with a friendlier face not associated directly with the brand industry.
Time To Tip the Scales? Humira Biosimilars And The Limitations Of Competition In US Health Care
In year two, Humira biosimilar uptake – or the lack thereof – continues to build the case for policy reform to incentivize use of cheaper biologics in the outpatient setting.
Company Information
- Industry
- Pharmaceuticals
- Services
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice